Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
Molecular Cancer, 07/02/09
Hesson LB et al. - The study shows the hypermethylation profile of RASSF genes in leukaemias is distinct from that of solid tumours and represents the first report of inactivation of RASSF6 or RASSF10 in cancer. These data show epigenetic inactivation of RASSF6 and RASSF10 is an extremely frequent event in the pathogenesis of childhood leukaemia. This study also warrants further investigation of the newly identified RASSF member RASSF10 and its potential role in leukaemia.
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Today in Pediatrics...keeping you current
Receive free subspecialty "5-minute updates" via email
Objective assessments of allergic and nonallergic rhinitis in young children
Allergy, 09/21/09
Diclofenac for acute pain in children
Cochrane Reviews, 10/08/09
Management of acute appendicitis: an imaging strategy in children
Pediatric Surgery International, 10/27/09
Article Search
Sponsor


See Latest Articles


